The more I look at this Veritas report the more I believe we are undervalued in their comparisons... not even mentioning the use of USD$2.90 for Cu.
Looking at the bubble graph they used (below) lets look at the 'peers' near us on the graph:
Regulus - High Arsenic levels in resource, location issues being high in the Andes
Xanadu - Big issues again with location (look what RIO are going through with Oyu Tolgoi in the same area)
Los Andes - I actually want to do more research into this one as it looks interesting, only thing would be location (distance to port and elevation being in the Andes being twice what HCH has to deal with) but project looks great
Serengeti - Can't see anything on Arsenic levels, project is alot smaller and looks unlikely to grow significantly, location is ok.
Personally I dont think REG or XAM should be in the comparisons as they are just not in the same park as the others and if those are taken our I wonder what the current insitu CuEq / $ value would be... i would guess well north of $52.60/t
- Forums
- ASX - By Stock
- HCH
- Ann: Cortadera Acquisition Nears Completion
Ann: Cortadera Acquisition Nears Completion, page-104
-
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCH (ASX) to my watchlist
|
|||||
Last
81.5¢ |
Change
0.030(3.82%) |
Mkt cap ! $123.3M |
Open | High | Low | Value | Volume |
81.0¢ | 83.0¢ | 80.0¢ | $75.89K | 93.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 161547 | 80.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
81.5¢ | 17456 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 161547 | 0.800 |
1 | 2412 | 0.795 |
2 | 7412 | 0.790 |
2 | 3052 | 0.785 |
4 | 29912 | 0.780 |
Price($) | Vol. | No. |
---|---|---|
0.815 | 17456 | 1 |
0.820 | 7583 | 2 |
0.830 | 4605 | 1 |
0.835 | 11538 | 1 |
0.840 | 4444 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
HCH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online